Vancouver
Vural H, Tamer MN, Weiskirchen R. Evaluation of Arginine-Nitric Oxide Pathway in Patients with Hyperthyroidism. ELECTRON J GEN MED. 2021;18(2):em278. https://doi.org/10.29333/ejgm/9696
APA
Vural, H., Tamer, M. N., & Weiskirchen, R. (2021). Evaluation of Arginine-Nitric Oxide Pathway in Patients with Hyperthyroidism. Electronic Journal of General Medicine, 18(2), em278. https://doi.org/10.29333/ejgm/9696
AMA
Vural H, Tamer MN, Weiskirchen R. Evaluation of Arginine-Nitric Oxide Pathway in Patients with Hyperthyroidism. ELECTRON J GEN MED. 2021;18(2), em278. https://doi.org/10.29333/ejgm/9696
Chicago
Vural, Huseyin, Mehmet Numan Tamer, and Ralf Weiskirchen. "Evaluation of Arginine-Nitric Oxide Pathway in Patients with Hyperthyroidism". Electronic Journal of General Medicine 2021 18 no. 2 (2021): em278. https://doi.org/10.29333/ejgm/9696
Harvard
Vural, H., Tamer, M. N., and Weiskirchen, R. (2021). Evaluation of Arginine-Nitric Oxide Pathway in Patients with Hyperthyroidism. Electronic Journal of General Medicine, 18(2), em278. https://doi.org/10.29333/ejgm/9696
MLA
Vural, Huseyin et al. "Evaluation of Arginine-Nitric Oxide Pathway in Patients with Hyperthyroidism". Electronic Journal of General Medicine, vol. 18, no. 2, 2021, em278. https://doi.org/10.29333/ejgm/9696